The Journal of Dental Sciences (JDS) is the official peer-reviewed and SCIE-indexed journal of the Association for Dental Sciences of the Republic of China. The Journal is also indexed in ScienceDirect, SCOPUS, SIIC Data Bases and EMCare, and is published quarterly by Elsevier.
Authors are welcome to submit original contributions on clinical and laboratory research in the dental sciences and related fields.
The Editorial Board requires authors to be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs), which are compiled by the International Committee of Medical Journal Editors (ICMJE); current URMs are available at http://www.icmje.org.
The categories of articles that are published in the Journal are listed and described below. Please select the category that best describes your paper. If your paper does not fall into any of these categories, please contact the Editorial Office.
These are comments on recent news or groundbreaking work and should provide a short review of the current state of research and explain the importance of the new findings. Perspectives on papers previously published in the JDS should add a different viewpoint to the research and should not merely be a repetitive summary of the original paper. Although many of the Perspectives published in the Journal are normally invited, unsolicited Perspectives are welcome and will be given due consideration.
As these are meant to express a personal commentary, with rare exceptions.
• Authors: up to 3
• Word limit: 1000 words
• References: up to 10
• Tables/Figures: 1 maximum
These should aim to provide the reader with a balanced overview of an important and topical issue in research or clinical practice. They should cover aspects of a topic in which scientific consensus exists as well as aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated.
Format guide• Abstract: required, up to 250 words, unstructured (i.e., no subheadings)
• Keywords: up to 10
• Word limit: 3500 words
• References: up to 100
• Tables/Figures: 1 maximum
These articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal studies, cohort studies, cost-effectiveness analyses, case-control studies, and surveys with high response rates, which represent new and significant contributions to the field.
Section headings should be: Abstract, Introduction, Materials and methods, Results, Discussion, Conflicts of Interest Statement, Acknowledgments (if any), and References.
The Introduction should provide a brief background to the subject of the paper, explain the importance of the study, and state a precise study question or purpose.
The Materials and methods section should describe the study design and methods (including the study setting and dates, patients/participants with inclusion and exclusion criteria, patient samples or animal specimens used, the essential features of any interventions, the main outcome measures, the laboratory methods followed, or data sources and how these were selected for the study), and state the statistical procedures employed in the research.
The Results section should comprise the study results presented in a logical sequence, supplemented by tables and/or figures. Take care that the text does not repeat data that are presented in tables and/or figures. Only emphasize and summarize the essential features of the main outcome measures, and the main results.
The Discussion section should be used to emphasize the new and important aspects of the study, placing the results in context with published literature, the implications of the findings, and the conclusions that follow from the study results.
• Abstract: required, up to 250 words
• Keywords: up to 10
• Word limit: 2500 words
• References: up to 40
These are short discussions of a case or case series with unique features not previously described that make an important teaching point or scientific observation. They may describe novel techniques or use of equipment, or new information on diseases of importance. Section headings should be: Abstract, Introduction, Case Report, Discussion, Conflicts of Interest Statement (if any), Acknowledgments (if any), and References.
The Introduction should describe the purpose of the present report, the significance of the disease and its specificity, and briefly review the relevant literature.
The Case Report should include statements of the problem, patient history, diagnosis, treatment, outcome and any other information pertinent to the case(s).
The Discussion should compare, analyze and discuss the similarities and differences between the reported case and similar cases reported in other published articles. The importance or specificity of the case should be restated when discussing the differential diagnoses. Suggest the prognosis of the disease and possibility of prevention.
Case reports should have no more than 6 authors. The maximum length is 1500 words, and the number of references should not exceed 10.
*The JDS is currently not accepting any submissions of Case Reports due to the large number of as yet unpublished but accepted Case Reports. Once this backlog of Case Reports has been cleared, the Editors will reassess the situation. Please watch this space for further updates.
These reports should be concise presentations of preliminary experimental results, instrumentation and analytical techniques, or aspects of clinical or experimental practice that are not fully investigated, verified or perfected but which may be of widespread interest or application. The Editors reserve the right to decide what constitutes a Short Communication.
Format guide• Authors: up to 6
• Abstract: required, up to 150 words
• Keywords: up to 10
• Word limit: 1500 words
• References: up to 10
• Tables/Figures: 2 maximum
These typically include interesting cases that do not meet the requirement of being truly exceptional.
• Abstract: not required
• Word limit: 1000 words
• References: up to 10
These include short case reports, technical or clinical notes and short comments on previously published articles. The Editors reserve the right to decide what constitutes a Correspondence.
Format guide• Number of authors: up to 4
• Abstract: not required
• Keywords: up to 10
• Word limit: 500 words
• References: up to 5
• Tables/Figures: 1 maximum
Letters to the Editor
Brief letters of constructive comments in response to previously published JDS articles are welcome. Ensure that the corresponding author's mailing and e-mail addresses are included. Letters are edited, sometimes extensively, to sharpen their focus. They may be sent for peer review at the discretion of JDS Editors. Letters are selected based on clarity, significance, and space.
• Author: up to 3
• Word limit: 250 words
• Tables/Figures: 1 maximum
For human or animal experimental investigations, appropriate institutional review board or ethics committee approval is required, and such approval should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf).
For investigations in humans, state explicitly in the methods section of the manuscript that informed consent was obtained from all participating adults and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (ex. oral or written).
For work involving animals, the guidelines for their care and use that were followed should be stated in the methods section of the manuscript. For those investigators who do not have formal institutional guidelines relating to animal experiments, the European Commission Directive 86/609/EEC for animal experiments (available at http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm) should be followed and the same should be stated in the methods section of the manuscript.
Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual's objectivity is potentially compromised by a desire for financial gain, prominence, professional advancement or a successful outcome. JDS Editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. Since it is difficult to distinguish between an actual conflict of interest and a perceived conflict of interest, the Journal requires authors to disclose all and any potential conflicts of interest.
Conflicts of interest may be financial or non-financial. Financial conflicts include financial relationships such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; expert testimony or patent-licensing arrangements. Non-financial conflicts include personal or professional relationships, affiliations, academic competition, intellectual passion, knowledge or beliefs that might affect objectivity.
Please ensure that the name of each author listed in your manuscript appears in either Section I or Section II on the page 2 of the JDS Authorship & Conflicts of Interest Statement form (an author’s name cannot appear in both Section I and Section II of the form).
Since it is difficult to distinguish between an actual conflict of interest and a perceived conflict of interest, the JDS requires authors to disclose all and any potential conflicts of interest and let readers judge for themselves. Therefore, please ensure that you provide information about any potential financial and non-financial conflicts of interest (see Section 2 for more information) in a concise paragraph after the main text.All financial and material support for the research, work, writing and editorial assistance from internal or external agencies, including commercial companies, should be clearly and completely identified in a Funding/Support Statement.
Reporting Clinical Trials
All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart (please go to http://www.consort-statement.org for more information). The JDS has adopted the ICMJE proposal that requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.
For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at http://www.icmje.org.
Manuscripts published in the JDS become the permanent property of the Association for Dental Sciences of the Republic of China. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No JDS article, in part or whole, may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from the Association for Dental Sciences of the Republic of China.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information (http://elsevier.com/greenopenaccess). Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and begins from the publication date of the issue your article appears in.
This journal has an embargo period of 12 months.
A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all persons (parents or legal guardians for minors) who can be identified (including by the patients themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Manuscripts (meaning all submission items, including all text, tables, artwork, cover letter, conflicts of interest disclosures, and any other required documents/material) must be submitted online to the JDS through Elsevier's Editorial System (EES). This system can be accessed at http://ees.elsevier.com/jds. This site will guide authors stepwise through the submission process. If assistance is required, please refer to the tutorials and/or customer support that are available on the EES website; you may also contact the Editorial Office. Please do not post, fax or e-mail your manuscripts to the Editorial Office.
Council on Publication
Association for Dental Sciences of the Republic of China
3F, No. 36, Hengyang Road, Taipei 10045, Taiwan
Tel: (+886) (0)2 2311-6001
Fax: (+886) (0)2 2311-6080
- Articles should be in Microsoft Word document format and prepared in the simplest form possible. We will add in the correct font, font size, margins and so on according to the journal’s style.
- You may use automatic page numbering, but do NOT use other kinds of automatic formatting such as footnotes, headers and footers. References especially should NOT be formatted using the MS Word ""endnotes"" or ""footnotes"" function; instead, you may use the commercially available EndNote or Reference Manager software to manage your references.
- Put text, references, table headings and tables, and figure legends in one file.
- Figures must be submitted as separate picture files, at the correct resolution and named according to the figure number, e.g., “Fig1.tif”, “Fig2.jpg”. Please see section "Figures" for more information.
The following documents must be included in your submission (refer also to the Checklist that is available at http://www.e-jds.com. Items (1), (2) and (3) are mandatory. Items (4), (5), (6) and (7) are required only if they are applicable to your manuscript.
- Cover Letter. This must include the following information:
- title of the manuscript
- corresponding author details (name, e-mail, mailing address, telephone and fax numbers)
- a statement that the material contained in the manuscript has not been previously published and is not being concurrently submitted elsewhere
- persons who do not fulfill the requirements to be listed as authors but who nevertheless contributed to the manuscript (such as those who provided writing assistance, for example) should be disclosed
- list of manuscripts that have been published, submitted, or are in press that are similar to the submission to the JDS (and include in your submission copies of those similar manuscripts so that JDS Editors can be assured there is no overlap)
- your signature and those of ALL your coauthors
- Optional: if you have a list of reviewers who you wish to review or not to review your manuscript, you may include this list in the cover letter
- Authorship & Conflicts of Interest Statement. Each author's contribution to the manuscript should be listed. Any and all potential and actual conflicts of interest should also be listed (see Section 2 for more information). Please use the JDS Authorship & Conflicts of Interest Statement form that is provided on the Journal's website at http://www.e-jds.com. Your signature and those of ALL your coauthors must be included.
- Copyright Transfer Agreement. In the event that your manuscript is accepted for publication in the JDS, you are required to transfer all copyright ownership in and relating to the work to Association for Dental Sciences of the Republic of China. Please use the JDS Copyright Transfer Agreement form that is provided on the Journal's website at http://www.e-jds.com. Your signature and those of ALL your coauthors must be included.
- Ethics Statement. Articles covering the use of human or animal samples in research, or human or animal experiments must be accompanied by a letter of approval from the relevant review committee or authorities. See Section 3 for more information.
- Consolidated Standards of Reporting Trials (CONSORT) flow chart for randomized controlled trials submitted for publication. See Section 4 for more information.
- Signed Statement of Informed Consent. Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs and pedigrees from each subject who can be identified. See Section 5 for more information.
- Copyright Permission. If you have reproduced or adapted material from other copyrighted sources, the letter(s) of permission from the copyright holder(s) to reproduce or adapt the copyrighted sources must be supplied. Otherwise, such material must be removed from your manuscript.
Submitted manuscripts are considered with the understanding that they have not been published previously in print or electronic format (except in abstract or poster form) and are not under consideration in totality or in part by another publication or electronic medium.
Submit your article
Please submit your article via http://ees.elsevier.com/jds.
Text should be typed double-spaced on one side of white A4 (297 × 210 mm) paper, with outer margins of 2.5 cm. A manuscript should include a title page, abstract, text, references, conflicts of interest statement (if any), acknowledgments (if any), and figures and tables as appropriate. Each section of the manuscript should begin on a new page. Pages should be numbered consecutively, beginning with the title page.
The title page should contain the following information (in order, from the top to bottom of the page):
- article category
- article title
- names (spelled out in full) of all authors*, and the institutions with which they are affiliated†; indicate all affiliations with a superscripted lowercase letter after the author's name and in front of the matching affiliation
- corresponding author details (name, e-mail, mailing address, telephone and fax numbers)
- running title not exceeding 50 characters
An abstract (no longer than 300 words) and 3-5 relevant keywords (in alphabetical order) are required for the following article categories: Review Articles, Original Articles, Case Reports and Brief Communications.Abstracts for Review Articles, Case Reports and Short Communications should be unstructured (in one single paragraph with no section headings), and include information on the background/purpose of the report, methods, results (or case report), and conclusions
Abstracts for Original Articles should be structured into the following sections.
- Background/Purpose: briefly explain the importance of the study topic and state a precise study question or purpose.
- Materials and methods: briefly introduce the methods used to perform the study; include information on the study design, setting, subjects, interventions, outcome measures and analyses as appropriate.
- Results: briefly present the significant results, with data and statistical details such as p values where appropriate; be sure that information in the abstract matches that in the main text.
- Conclusion: state the meaning of your findings, being careful to address the study question directly and to confine your conclusions to aspects covered in the abstract; give equal emphasis to positive and negative findings.
No abstract or keywords are required for Perspectives, Research Letters, Correspondence and Letters to the Editor.Main Text
The text for Original Articles and Short Communications should be organized into the following sections: Introduction, Materials (or Patients) and methods, Results, Discussion, Conflicts of interest statement, Acknowledgments (if any), and References. Subheadings in long papers are acceptable if needed for clarification and ease of reading. Sections for Case Reports are: Introduction, Case report, Discussion, Conflicts of interest statement (if any), Acknowledgments (if any), and References. Each section should begin on a new page.
Where a term/definition will be continually referred to, it must be written in full when it first appears in the text, followed by the subsequent abbreviation in parentheses. Thereafter, the abbreviation may be used. An abbreviation should not be first defined in any section heading; if an abbreviation has previously been defined in the text, then the abbreviation may be used in a subsequent section heading. Restrict the number of abbreviations to those that are absolutely necessary and ensure consistency of abbreviations throughout the article. Ensure that an abbreviation so defined does actually appear later in the text (excluding in figures/tables), otherwise, it should be deleted..
Numbers that begin a sentence or those that are less than 10 should be spelled out using letters. Centuries and decades should be spelled out, e.g., the Eighties or nineteenth century. Laboratory parameters, time, temperature, length, area, mass, and volume should be expressed using digits.
Système International (SI) units must be used, with the exception of blood pressure values which are to be reported in mmHg. Please use the metric system for the expression of length, area, mass, and volume. Temperatures are to be given in degrees Celsius.
Names of drugs, devices and other products
Use the Recommended International Nonproprietary Name (rINN) for medicinal substances, unless the specific trade name of a drug is directly relevant to the discussion. Generic drug names should appear in lowercase letters in the text. If a specific proprietary drug needs to be identified, the brand name may appear only once in the manuscript in parentheses following the generic name the first time the drug is mentioned in the text.
For devices and other products, the specific brand or trade name, the manufacturer and their location (city, state, country) should be provided the first time the device or product is mentioned in the text, for example, ""¡KSPSS version 11 was used (SPSS Inc., Chicago, IL, USA)"". Thereafter, the generic term (if appropriate) should be used.
Current standard international nomenclature for genes should be adhered to. For human genes, use genetic notation and symbols approved by the HUGO Gene Nomenclature Committee (http://www.genenames.org). You may also refer to the resources available on PubMed at http://www.ncbi.nlm.nih.gov/guide/genes-eK65K56K39xpression. The Human Genome Variation Society has a useful site that provides guidance in naming mutations at http://www.hgvs.org/mutnomen/index.html. In your manuscript, genes should be typed in italic font and include the accession number.
Statistical analysis is essential for all research papers except Case Reports. Use correct nomenclature of statistical methods (e.g., two sample t test, not unpaired t test). Descriptive statistics should follow the scales used in data description. Inferential statistics are important for interpreting results and should be described in detail.
All p values should be presented to the third decimal place for accuracy. The smallest p value that should be expressed is p < 0.001, since additional zeros do not convey useful information; the largest p value that should be expressed is p > 0.99.
Personal communications and unpublished data
These sources cannot be included in the references list but may be described in the text. The author(s) must give the full name and highest academic degree of the person, the date of the communication, and indicate whether it was in oral or written (letter, fax, e-mail) form. A signed statement of permission should be included from each person identified as a source of information in a personal communication or as a source for unpublished data.
Tables should supplement, not duplicate, the text. They should have a concise table heading, be self-explanatory, and numbered consecutively in the order of their citation in the text. Items requiring explanatory footnotes should be denoted using superscripted lowercase letters (a, b, c, etc.), with the footnotes arranged under the table in alphabetical order. Asterisks (*, **) are used only to indicate the probability level of tests of significance. Abbreviations used in the table must be defined and placed after the footnotes in alphabetical order. If you include a block of data or table from another source, whether published or unpublished, you must acknowledge the original source.
The number of figures should be restricted to the minimum necessary to support the textual material. Figures should have an informative figure legend and be numbered in the order of their citation in the text. All symbols and abbreviations should be defined in the figure legend in alphabetical order. Items requiring explanatory footnotes should follow the same style as that for tables as described in Section "Tables"
Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details (such as their name and date of birth) of the patient must be removed. If their face is shown, use a black bar to cover their eyes so that they cannot be identified (for further information, see http://www.elsevier.com/patientphotographs).
All lettering should be done professionally and should be in proportion to the drawing, graph or photograph. Photomicrographs must include an internal scale marker, and the legend should state the type of specimen, original magnification and stain.
Figures must be submitted as separate picture files at the correct resolution (see Section 9.8.2 below). The files should be named according to the figure number, e.g., “Fig1.tif”, “Fig2.jpg”.
Regardless of the application used, when your electronic artwork is finalized, please “save as” or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
- EPS: Vector drawings. Embed the font or save the text as “graphics”.
- TIFF: Color or grayscale photographs (halftones) — always use a minimum of 300 dpi.
- TIFF: Bitmapped line drawings — use a minimum of 1000 dpi.
- TIFF: Combination of bitmapped line/half-tone (color or grayscale) — a minimum of 600 dpi.
- DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications, please supply “as is”.
- Supply files that do not meet the resolution requirements detailed above;
- Supply files that are optimized for screen use (such as GIF, BMP, PICT, WPG) as the resolution is too low;
- Submit graphics that are disproportionately large for the content.
A detailed guide on electronic artwork is available at http://www.elsevier.com/artworkinstructions.
Please note that the cost of color illustrations will be charged to the author. (see Section 12 for more information)
The Editorial and Peer Review ProcessAs a general rule, the receipt of a manuscript will be acknowledged within 1 week of submission, and authors will be provided with a manuscript reference number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office.
Manuscripts are reviewed by the Editorial Office to ensure that the submission contains all parts. The submission will not be accepted if the author has not supplied all parts of the manuscript as outlined in this document.
Manuscripts are then forwarded to the Editor-in-Chief, who makes an initial assessment of it. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, then the manuscript will be rejected promptly without review. Note that the Journal is currently not accepting any Case Reports due to the large number of as yet unpublished but accepted Case Reports. (Once this backlog of Case Reports has been cleared, the Editors will reassess the situation.)
Manuscripts that appear meritorious and appropriate for the Journal are reviewed by at least two Editorial Board members or expert consultants assigned by the Editor-in-Chief. The JDS follows a double-blind peer review process. Authors may submit a list in their cover letter of reviewers who they wish to review or not to review their manuscript. However, the actual peer reviewers invited will remain anonymous and may or may not be the reviewers suggested by the authors as the selection of reviewers is at the sole discretion of JDS Editors. The editors and reviewers will not disclose any information about a manuscript or its review to anyone except the manuscript's corresponding author.
The corresponding author will usually be notified within 10 weeks of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance (however, do note that delays are sometimes unavoidable). If revisions are required, authors are asked to return a revised manuscript to the Editorial Office via the EES within 60 days. Please notify the Editorial Office in advance if additional time is needed or if you choose not to submit a revised manuscript.
Pre-final Acceptance English Editing/Polishing
Your manuscript should be edited and polished by a native English speaker before final acceptance. Authors should return the revised manuscript with a language editing/polishing certificate or authors may choose to use the English editing/polishing service provided by the Editorial Office. Please contact the Editorial Office if the service is required and for information on the charges. The Editorial Office reserves the right to rescind the accept decision if the manuscript does not undergo English editing/polishing.
Preparation for Publication
Once a manuscript has been accepted for publication and completed English editing/polishing, authors should submit the final version of their manuscript in MS Word format, with all tables/figures as applicable, via the EES. Accepted manuscripts are then presented to the Publisher to be copyedited according to the Journal's style and the galley proofs in the form of a PDF file are sent by the Publisher to the corresponding author for final approval. Authors are responsible for all statements made in their work, including changes made by the copy editor. Proofreading is solely the authors' responsibility. Note that the Editorial Board reserves the right to make revisions to the manuscript and the Publisher may proceed with the publication of your article if no response from the author(s) is received.
Changes to Authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts. Before the accepted manuscript is published online, requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (i) the reason the name should be added or removed, or the author names rearranged; and (ii) an updated Authorship & Conflicts of Interest Statement with signatures from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of author names, this must include confirmation from the author(s) being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedures as described above.Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) online publication of the accepted manuscript is suspended until authorship has been agreed.After the accepted manuscript is published online, any requests to add, remove, or rearrange author names in an article will follow the same policies as detailed above and result in a corrigendum.
After the Conflicts of Interest Statement and/or Funding/Support Statement, general acknowledgments for consultations and statistical analyses should be listed concisely, including the names of the individuals who were directly involved. Consent should be obtained from those individuals before their names are listed in this section. Those acknowledged should not include secretarial, clerical or technical staff whose participation was limited to the performance of their normal duties.
Authors are responsible for the accuracy and completeness of their references and for correct in-text citation. If massive corrections to the references are found to be necessary in the event that your manuscript is accepted, JDS Editors reserve the right to rescind the accept decision and reject the article.
- References should be indicated by superscripted numbers according to order of appearance in the text, and placed after punctuation. [The actual authors can be referred to, but the reference number(s) must always be given.]
- References cited in tables or figure legends should be included in sequence at the point where the table or figure is first mentioned in the main text.
- Do not cite abstracts unless they are the only available reference to an important concept.
- Do not cite uncompleted work or work that has not yet been accepted for publication (i.e., “unpublished observation”, “personal communication”) as references. Also see Section 9.3.7.
In the references list
- References should be limited to those cited in the text and listed in numerical order, NOT alphabetical order.
- References should include, in order, authors’ surnames and initials, article title, abbreviated journal name, year, volume and inclusive page numbers.
- The surnames and initials of all the authors up to 6 should be included, but when authors number 7 or more, list the first 3 authors only followed by “et al”.
- Abbreviations for journal names should conform to those used in MEDLINE.
- If citing a website, provide the author information, article title, website address and the date you accessed the information.
- Reference to an article that is in press must state the journal name and, if possible, the year and volume.
- Authors are responsible for the accuracy and completeness of their references and for correct text citation.
Standard journal articles
Lin SS, Lai JP, Yen YY, Chen IC, Kuo AH, Yeh IC. Investigation into the prediction accuracy of photocephalometry for skeletal Class III adult female patients treated with two-jaw surgery. J Dent Sci 2012;7:137-47.
Kaplan NM. The endothelium as prognostic factor and therapeutic target: what criteria should we apply? J Cardiovasc Pharmacol 1998;32(Suppl 3):S78–80.
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma-five years survival rate. Laryngorhinootologie 2002;81:342-5. [In German, English abstract]
Book with edition
Bradley EL. Medical and Surgical Management. 2nd ed. Philadelphia: Saunders; 1982, p. 72–95.
Letheridge S, Cannon CR, editors. Bilingual Education: Teaching English as a Second Language. New York: Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: Underwood JCE, editor. General and Systematic Pathology. 4th ed. London: Churchill Livingstone; 2004, p. 615–72.
Wilson JG, Fraser FC, editors. Handbook of Teratology, vols. 1-4. New York: Plenum Press; 1977-1978.
World Health Organization. World Health Report 2002: Reducing Risk, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
Duchin JS. Can preparedness for biological terrorism save us from pertussis? Arch Pediatr Adolesc Med 2004;158(2). Available from: http://archpedi.amaassn. org/cgi/content/full/158/2/106. [Date accessed: June 12, 2004]
Items presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head and neck cancer recurrence and second primary tumors. In: Proceedings from the American Society of Clinical Oncology; May 31–June 3, 2003; Chicago, IL. Abstract 359.
Cionni RJ. Color perception in patients with UV- or blue-light-filtering IOLs. In: Symposium on Cataract, IOL, and Refractive Surgery. San Diego, CA: American Society of Cataract and Refractive Surgery; 2004. Abstract 337.
Ayers AJ. Retention of Resin Restorations by Means of Enamel Etching and by Pins. MSD thesis, Indiana University School of Dentistry, Indianapolis, 1971.
American Association of Oral and Maxillofacial Surgeons. Wisdom Teeth. Rosemont, IL: AAOMS, 2008. Available at: http://www.aaoms.org/wisdom_teeth.php [Date accessed: November 15, 2008]
Eastman Kodak Company, Eastman Organic Chemicals. Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, p. 2–3.
Authors of accepted articles will be charged a publication fee as follows: US$400 for Original Articles; US$200 for Short Communications and Research Letters. (No publication fee will be charged for Invited Review Articles, Perspectives, Correspondence and Letters to the Editor.) The Journal will bear the cost of publication for articles of 7 printed pages or less for Review Articles and Original Articles, and 2 printed pages or less for Perspectives, Case Reports, Short Communications, Research Letters and orrespondence. Authors will be charged US$167 per extra page. Authors will also be charged US$84 per illustration, figure or table that is in color.
In the event that a manuscript is accepted, the corresponding author will be instructed by the Editorial Office on how to transmit their payment to the Journal. The accepted article will be processed to the next stage only upon receipt of payment.
Professional reprints (which include a cover page) of your article may be ordered from the Publisher at prices based on the cost of production. A reprint order form can be downloaded from the Journal’s website at http://www.e-jds.com.Forms
• Authorship & Conflict of Interest Statement
• Copyright Transfer Statement